I had a feeling about this. The company says my engineered T-cells are “out of spec.” The Mayo coordinator of course was given no clue what that means, but it’s clear I will not be getting them re-infused as scheduled on March 23rd. Next week we’ll meet with the Scottsdale Mayo CAR-T specialist who we hope will have learned more. Whether it’s worth taking a chance on these or we’re better off switching to teclistamab may be more clear by then. Maybe Nancy will get to visit Havasupai Falls in April after all; I doubt teclistamab will have as stringent or lengthy a 24/7 babysitter requirement.